CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Quince Therapeuticks Inc - QNCX CFD

0.6932
2.82%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0370
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.6807
Open 0.7049
1-Year Change -52.33%
Day's Range 0.6977 - 0.7073
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 24, 2024 0.6932 -0.0117 -1.66% 0.7049 0.7077 0.6845
Jun 21, 2024 0.6807 0.0525 8.36% 0.6282 0.7033 0.6227
Jun 20, 2024 0.6405 -0.0443 -6.47% 0.6848 0.6848 0.6383
Jun 18, 2024 0.6677 -0.0228 -3.30% 0.6905 0.7027 0.6677
Jun 17, 2024 0.7003 0.0054 0.78% 0.6949 0.7119 0.6925
Jun 14, 2024 0.7008 0.0059 0.85% 0.6949 0.7089 0.6899
Jun 13, 2024 0.6846 -0.0360 -5.00% 0.7206 0.7206 0.6419
Jun 12, 2024 0.7024 -0.0523 -6.93% 0.7547 0.7605 0.6963
Jun 11, 2024 0.7547 0.0190 2.58% 0.7357 0.7577 0.7357
Jun 10, 2024 0.7496 -0.0352 -4.49% 0.7848 0.7848 0.7496
Jun 7, 2024 0.7795 -0.0150 -1.89% 0.7945 0.8045 0.7223
Jun 6, 2024 0.8046 0.0001 0.01% 0.8045 0.8065 0.7672
Jun 5, 2024 0.8114 -0.0230 -2.76% 0.8344 0.8543 0.8086
Jun 4, 2024 0.8707 0.0363 4.35% 0.8344 0.8707 0.8058
Jun 3, 2024 0.8346 -0.0694 -7.68% 0.9040 0.9042 0.8346
May 31, 2024 0.8151 -0.0127 -1.53% 0.8278 0.8477 0.8151
May 30, 2024 0.8203 -0.0141 -1.69% 0.8344 0.8377 0.8203
May 29, 2024 0.8402 0.0058 0.70% 0.8344 0.8577 0.8288
May 28, 2024 0.8232 -0.0112 -1.34% 0.8344 0.8374 0.8156
May 24, 2024 0.8443 -0.0100 -1.17% 0.8543 0.8627 0.8250

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cortexyme Inc. Company profile

About Cortexyme Inc

Cortexyme, Inc. is a clinical stage biopharmaceutical company that is focused on providing disease-modifying therapeutics to treat Alzheimer's and other degenerative diseases. The Company provides 3CLpro inhibitor, COR803 product, is a lead compound for treatment of coronavirus infections. The Company’s products pipeline includes drug candidates for the treatment of central nervous system (CNS) disorders including Alzheimer’s disease; for the treatment of oncology applications including the prevention of oral squamous cell carcinoma, and for the treatment of underserved and chronic conditions such as periodontitis. The Company’s COR388 is for the treatment of Alzheimer’s disease and Parkinson's disease. The Company's COR588 is in Phase I clinical trial and targeting to use in the treatment of periodontal disease and other P. gingivalis-related indications. The Company is also developing COR588, is a second-generation brain penetrant lysine gingipain inhibitor.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Cortexyme Inc revenues was not reported. Net loss increased 17% to $89.9M. Higher net loss reflects Stock-based Compensation in R&D increase from $7M to $15.1M (expense), Stock-based Compensation in GA increase of 99% to $14.8M (expense), General and administrative - Balancing increase of 45% to $14.7M (expense).

Industry: Biotechnology & Medical Research (NEC)

601 Gateway Boulevard, Suite 1250
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

News

Bank of England preview: no rate cut just yet despite CPI returning to 2%

The Bank of England (BoE) is widely expected to keep rates unchanged when it meets on Thursday. Analyst Daniela Harthorn looks at what this could mean

12:45, 18 June 2024

RBA Meeting Preview: No change to policy expected, markets look for fresh guidance

The Reserve Bank of Australia is expected to keep interest rates unchanged at 4.35% when it meets on Tuesday, June 18th, 2024, at 2:30 PM (AEST).

13:17, 17 June 2024

FOMC Decision Review: Rates unchanged as central bank raises inflation and interest rate forecasts

The FOMC left Federal Funds Rate unchanged at a target range of 5.25 to 5.50%.

10:55, 17 June 2024

Bank of Japan Preview: Markets look for guidance from BOJ about timing of next hike

The Bank of Japan meets on Friday, 14th of June, 2024. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

11:05, 12 June 2024

FOMC preview: Still expecting three rate cuts in 2024?

The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?

08:20, 11 June 2024

US Non-Farm Payrolls Preview: Forecasts point to a stable labour market

US labour market conditions are expected to have remained stable in May. The latest Non-Farm Payrolls data will be released on Friday, June 7th, 2024, and will provide a health check on the US jobs market.

10:09, 5 June 2024

AUD/USD analysis: Focus turns to GDP data after unexpected CPI rise

Higher-than-expected monthly CPI data watered down expectations for RBA interest rate cuts in 2024; the markets will now shift attention to quarterly GDP data on Wednesday, June 5.

15:57, 4 June 2024

People also watch

BTC/USD

61,259.75 Price
+2.920% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

ETH/USD

3,375.81 Price
+1.940% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.48 Price
+1.830% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

19,573.50 Price
+0.490% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 620,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading